Literature DB >> 22222989

The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae.

C Blauwendraat1, G L J Dixon, J C Hartley, J Foweraker, K A Harris.   

Abstract

Mycobacterium abscessus [M. abscessus (sensu lato) or M. abscessus complex] comprises three closely related species: M. abscessus (sensu stricto), hereafter referred to as M. abscessus, M. bolletii and M. massiliense. We describe here an accurate and robust method for distinguishing M. chelonae from M. abscessus, M. bolletii and M. massiliense, using polymerase chain reaction (PCR) and the sequencing of house-keeping gene targets (hsp65 and rpoB). Sequencing of the sodA gene is of little additional value in discriminating between species, but M. massiliense can be rapidly identified by amplification of the truncated erm(41) gene without the need for amplicon sequencing. We have applied the method to 81 isolates from 40 patients from two hospitals, the majority of whom were cystic fibrosis (CF) patients. Of these patients, 21 had previously been identified as M. chelonae and 59 as M. abscessus complex using commercial line probe assays. We identified these as 46 M. abscessus isolates, 20 M. massiliense isolates, five M. bolletii isolates and nine M. chelonae isolates and confirmed the one M. fortuitum isolate. This is the first study that has identified the individual members of the M. abscessus complex in a UK cohort of mainly CF patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222989     DOI: 10.1007/s10096-011-1510-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns.

Authors:  Hee-Youn Kim; Byoung Jun Kim; Yoonwon Kook; Yeo-Jun Yun; Jeong Hwan Shin; Bum-Joon Kim; Yoon-Hoh Kook
Journal:  Microbiol Immunol       Date:  2010-06       Impact factor: 1.955

2.  Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

Authors:  M Sanguinetti; F Ardito; E Fiscarelli; M La Sorda ; P D'Argenio; G Ricciotti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.

Authors:  Jennifer L Taylor; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2006-07-11       Impact factor: 10.247

4.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.

Authors:  Won-Jung Koh; Kyeongman Jeon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Sung Jae Shin; Gwen A Huitt; Charles L Daley; O Jung Kwon
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

5.  Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection.

Authors:  Marita Gilljam; Henrik Scherstén; Martin Silverborn; Bodil Jönsson; Annika Ericsson Hollsing
Journal:  J Cyst Fibros       Date:  2010-04-18       Impact factor: 5.482

6.  Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.

Authors:  F C Bange; B A Brown; C Smaczny; R J Wallace; E C Böttger
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

Review 7.  Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease.

Authors:  Edward D Chan; Xiyuan Bai; Marinka Kartalija; Ian M Orme; Diane J Ordway
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

8.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Authors:  Adrian M Zelazny; Jeremy M Root; Yvonne R Shea; Rhonda E Colombo; Isdore C Shamputa; Frida Stock; Sean Conlan; Steven McNulty; Barbara A Brown-Elliott; Richard J Wallace; Kenneth N Olivier; Steven M Holland; Elizabeth P Sampaio
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing.

Authors:  Toïdi Adékambi; Michel Drancourt
Journal:  Int J Syst Evol Microbiol       Date:  2004-11       Impact factor: 2.747

View more
  20 in total

1.  Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients.

Authors:  Kathryn A Harris; Dervla T D Kenna; Cornelis Blauwendraat; John C Hartley; Jane F Turton; Paul Aurora; Garth L J Dixon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

3.  New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance.

Authors:  Shamira J Shallom; Paul J Gardina; Timothy G Myers; Yinong Sebastian; Patricia Conville; Leslie B Calhoun; Hervé Tettelin; Kenneth N Olivier; Gulbu Uzel; Elizabeth P Sampaio; Steven M Holland; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

4.  Identification of Mycobacterium abscessus species and subspecies using the Cas12a/sgRNA-based nucleic acid detection platform.

Authors:  Guohui Xiao; Su Zhang; Zhihang Liang; Guanqiang Li; Mutong Fang; Yaya Liu; Juanjuan Zhang; Min Ou; Xing He; Tianyu Zhang; Changchun Zeng; Lei Liu; Guoliang Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

Review 5.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2016-12-19

6.  Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.

Authors:  Clair L Preece; Thomas A Wichelhaus; Audrey Perry; Amanda L Jones; Stephen P Cummings; John D Perry; Michael Hogardt
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

7.  New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.

Authors:  Shamira J Shallom; Natalia S Moura; Kenneth N Olivier; Elizabeth P Sampaio; Steven M Holland; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2015-08-12       Impact factor: 5.948

Review 8.  Mycobacterium abscessus Complex Infections in Children: A Review.

Authors:  Arick P Sabin; Patricia Ferrieri; Susan Kline
Journal:  Curr Infect Dis Rep       Date:  2017-10-05       Impact factor: 3.725

9.  Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology.

Authors:  Byoung-Jun Kim; Su-Yeon Yi; Tae-Sun Shim; Seung Yeon Do; Hee-Kyung Yu; Young-Gil Park; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

10.  Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients.

Authors:  Kathryn A Harris; Anthony Underwood; Dervla T D Kenna; Anthony Brooks; Ema Kavaliunaite; Georgia Kapatai; Rediat Tewolde; Paul Aurora; Garth Dixon
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.